Estimating Herbal Product Authentication and Adulteration in India Using a Vouchered, DNA-Based Biological Reference Material Library
- 361 Downloads
India is considered the ‘medicinal garden’ of the world, with 8000 medicinal plants of which 960 are commercial species that are traded nationally and globally. Although scientific studies estimate herbal product adulteration as 42–66 % in North America, India does not have any published marketplace studies and subsequent estimates of adulteration in an industry facing considerable supply demands.
The goal of this project is to provide an initial assessment of herbal product authentication and adulteration in the marketplace in India by (1) developing a biological reference material (BRM) herbal DNA library for Indian herbal species using DNA barcode regions (ITS2 and rbcL) in order to facilitate accurate species resolution when testing the herbal products; and (2) assessing herbal product identification using our BRM library; and (3) comparing the use of our BRM library to identify herbal products with that of GenBank.
A BRM herbal DNA library consisting of 187 herbal species was prepared to authenticate the herbal products within India. Ninty-three herbal products representing ten different companies were procured from local stores located at Coimbatore, India. These samples were subjected to blind testing for authenticity using the DNA barcode regions rbcL and ITS2.
The results indicate that 40 % of the products tested are authentic, and 60 % of the products may be adulterated (i.e. contained species of plants not listed on the product labels). The adulterated samples included contamination (50 %), substitution (10 %) and fillers (6 %). Our BRM library provided a 100 % Basic Local Alignment Search Tool (BLAST) match for all species, whereas the GenBank match was 64 %.
Our findings suggest that most Indian herbal medicinal products are essentially mixed with one or a few other herbs that could lessen the therapeutic activity of the main ingredients. We do not recommend the use of GenBank to identify herbal products because the use of this non-curated and/or vouchered database will result in inaccurate species identification. These DNA-based tools provide a scientific foundation for herbal pharmacovigilance to ensure the safety and efficacy of natural drugs. This study provides curated BRMs that will underpin innovations in molecular diagnostic biotechnology, which will soon provide more robust estimates of adulteration and commercial tools that will strengthen due diligence in quality assurance within the herbal industry.
KeywordsrbcL Basic Local Alignment Search Tool Herbal Product Herbal Species United States Pharmacopeia
RS, SGN, SR and DS conceived and designed the study; DS and SM carried out the wet lab analysis; DS, RS, SGN and SR contributed in writing the manuscript; SGN, RS and SR carried out the final edits and submission; all authors read and approved the final manuscript.
Compliance with Ethical Standards
This work was supported in India by the Bharathiar University, University Grants Commission—Special Assistance Programme, Department of Science and Technology—Funds for Improvement of Science and Technology (DST-FIST) funds and Department of Biotechnology India (to RS), and in Canada by the International Science and Technology Partnership Canada and the Ontario Ministry of Economic Development, Trade and Employment (MEDI) (to SGN).
Conflict of interest
Dhivya Shanmughanandhan, Subramanyam Ragupathy, Steven G. Newmaster, Saravanan Mohanasundaram and Ramalingam Sathishkumar have no conflicts of interest that are directly relevant to the content of this study.
- 1.Joy PP, Thomas J, Mathew S, Skaria PB. Medicinal plants. Kerala Agricultural University. Aromatic and Medicinal Plants Research Station. 1998;2:1–211.Google Scholar
- 2.Mukherjee PK, Venkatesh M, Kumar V. An overview on the development in regulation and control of medicinal and aromatic plants in the Indian system of medicine. Bol Latinoam Caribe Plant Med Aromat. 2007;6:129–36.Google Scholar
- 3.World Health Organization. Traditional medicine. 2003. http://www.who.int/mediacentre/factsheets/2003/fs134/en/. Accessed 11 July 2016.
- 4.Meena AK, Bansal P, Kumar S. Plants-herbal wealth as a potential source of ayurvedic drugs. Asian J Tradit Med. 2009;4(4):152–70.Google Scholar
- 5.Kamboj VP. Herbal medicine. Curr Sci India. 2000;78(1):35–8.Google Scholar
- 6.Dubey NK, Kumar R, Tripathi P. Global promotion of herbal medicine: India’s opportunity. Curr Sci. 2004;86(1):37–41.Google Scholar
- 7.National Medicinal Plants Board, Government of India. 2000. http://nmpb.nic.in. Accessed 11 July 2016.
- 9.Schippmann U, Leaman DJ, Cunningham AB. Impact of cultivation and gathering of medicinal plants on biodiversity: global trends and issues. Biodiversity and the ecosystem approach in agriculture, forestry and fisheries. 2002. http://www.fao.org/docrep/005/y4586e/y4586e00.html. Accessed 14 May 2016.
- 10.Environmental Information System (ENVIS) Centre on Floral Diversity. 1994. http://bsienvis.nic.in/Database/RedlistedPlants_3940.aspx. Accessed 11 July 2016.
- 11.Hassali MA, Thambyappa J, Nambiar S, Shafie AA, Löfgren H. TRIPS, free trade agreements and the pharmaceutical industry in Malaysia. In: The new political economy of pharmaceuticals: production, innovation and TRIPS in the Global South. Basingstoke: Palgrave Macmillan; 2013. p. 152–66.Google Scholar
- 12.Dixit S, Pandey RC, Das M, Khanna SK. Food quality surveillance on colours in eatables sold in rural markets of Uttar Pradesh. J Food Sci Tech. 1995;32(5):373–6.Google Scholar
- 13.Kannan K, Tanabe S, Giesy JP, Tatsukawa R. Organochlorine pesticides and polychlorinated biphenyls in foodstuffs from Asian and oceanic countries. In: Reviews of environmental contamination and toxicology. New York: Springer; 1997. p. 1–55.Google Scholar
- 18.Seethapathy GS, Ganesh D, Kumar JUS, Senthilkumar U, Newmaster SG, Ragupathy S, et al. Assessing product adulteration in natural health products for laxative yielding plants, Cassia, Senna, and Chamaecrista, in Southern India using DNA barcoding. Int J Legal Med. 2015;129(4):693–700.CrossRefPubMedGoogle Scholar
- 20.Garlic A. The impediments preventing India from becoming a herbal giant. Curr Sci. 2004;87(3):275.Google Scholar
- 24.World Health Organization. WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants. Geneva: WHO; 2003.Google Scholar
- 27.Revathy SS, Rathinamala R, Murugesan M. Authentication methods for drugs used in Ayurveda, Siddha and Unani Systems of medicine: an overview. Int J Pharm Sci Res. 2012;38:2352–61.Google Scholar
- 34.Stoeckle MY, Gamble CC, Kirpekar R, Young G, Ahmed S, Little DP. Commercial teas highlight plant DNA barcode identification successes and obstacles. Nat Sci Rep. 2011;1:42.Google Scholar
- 35.Dhanya K, Sasikumar B. Molecular marker based adulteration detection in traded food and agricultural commodities of plant origin with special reference to spices. Curr Trends Biotechnol Pharm. 2010;4:454–89.Google Scholar
- 36.Kumar A, Sharma S. An evaluation of multipurpose oil seed crop for industrial uses (Jatropha curcas L.): a review. Ind Crops. Prod. 2008;28:1–10.Google Scholar
- 39.Hussain A, Wahab S, Rizvi A, Hussain MS. Macroscopical, anatomical and physico-chemical studies on leaves of Coccinia indica Wight & Arn., growing wildly in eastern Uttar Pradesh region of India. Ind J Nat Prod Resour. 2011;2:74–80.Google Scholar
- 40.Halde UK, Wake R, Patil N. Genus Sida—the plants with ethno medicinal and therapeutic potential. Golden Res Thoughts. 2011;1:1–4.Google Scholar
- 47.Fazekas AJ, Kuzmina ML, Newmaster SG, Hollingsworth PM. DNA barcoding methods for land plants. In: Kress WJ, Erickson DL, editors. DNA barcodes—methods in molecular biology. New York: Humana Press; 2012. p. 223–52.Google Scholar
- 50.Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2013;4:177.Google Scholar
- 52.Adepoju-Bello AA, Issa OA, Oguntibeju OO, Ayoola GA, Adejumo OO. Analysis of some selected toxic metals in registered herbal products manufactured in Nigeria. Afr J Biotechnol. 2014;11(26):6918–22.Google Scholar
- 56.Gair R. Heavy metal poisoning from ayurvedic medicines. B C Med J. 2008;50:105.Google Scholar
- 58.Jamil SS, Nizami Q, Salam M. Centella asiatica (Linn.) Urban: a review. Nat Prod Radiance. 2007;6(2):158–70.Google Scholar
- 59.Rameshkumar A. Profiling of phenolic compound through UPLC-MS/MS and study on pharmaceutical properties of Merremia emarginata (Burm. F.) [PhD thesis]. Bharathidasan University, Tiruchirappalli, Tamil Nadu, India 2013.Google Scholar
- 64.Peesa JP. Nephroprotective potential of herbal medicines: a review. Asian J Pharm Tech. 2013;3(3):115–8.Google Scholar
- 65.Malhotra SP, Dutta BK, Gupta RK, Gaur YD. Medicinal plants of the Indian arid zone. J Agric Trop Bot Appl. 1966;13:247–88.Google Scholar
- 67.Namita P, Mukesh R. Medicinal plants used as antimicrobial agents: a review. Int Res J Pharm. 2012;3(1):31–40.Google Scholar
- 70.Omaye ST. Food and nutritional toxicology. Boca Raton: CRC Press; 2004.Google Scholar
- 79.Verma N. Herbal medicines: regulation and practice in Europe, United States and India. Int J Herb Med. 2013;1:1–5.Google Scholar
- 80.UNESCO. Report of the International Bioethics Committee on Traditional Medicine Systems and their ethical implications. 2013. SHS/EGC/IBC-19/12/3 Rev. Paris: UNESCO; 2013.Google Scholar
- 81.Gupta AK. Quality standards of Indian medicinal plants, vol. 1. New Delhi: Indian Council of Medical Research (ICMR); 2003.Google Scholar
- 82.WHO. WHO traditional medicine strategy 2002–2005. http://whqlibdoc.who.int/hq/2002/who_edm_trm_2002.1.pdf. Accessed 1 June 2016.